SLC22A4 and Crohn disease: However, accumulation of ergothioneine and increased expression of SLC22A4 in other (injured) tissues have been observed in animal models of liver fibrosis(46), fatty liver disease(53) and chronic kidney disease disease(54); as well as in humans with Crohn’s disease(45).